https://www.selleckchem.com/products/rk-33.html
Repetitive treatment with 100 mg diclofenac over three days aggravated renal injury and caused upregulation of the pro-fibrotic marker fibronectin in the setting of subclinical AKI, but not in sham control kidneys. In conclusion, diclofenac aggravated renal injury in pre-existing subclinical AKI in a dose and time-dependent manner and already a single dose can cause progression to chronic kidney disease (CKD) in this model.Combined treatment is an effective strategy to improve anticancer therapy, but severe side effects frequently limit t
Curtir
Comentario
Compartilhar
